Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 27;13(6):963.
doi: 10.3390/genes13060963.

Multisystem Proteinopathy Due to VCP Mutations: A Review of Clinical Heterogeneity and Genetic Diagnosis

Affiliations
Review

Multisystem Proteinopathy Due to VCP Mutations: A Review of Clinical Heterogeneity and Genetic Diagnosis

Gerald Pfeffer et al. Genes (Basel). .

Abstract

In this work, we review clinical features and genetic diagnosis of diseases caused by mutations in the gene encoding valosin-containing protein (VCP/p97), the functionally diverse AAA-ATPase. VCP is crucial to a multitude of cellular functions including protein quality control, stress granule formation and clearance, and genomic integrity functions, among others. Pathogenic mutations in VCP cause multisystem proteinopathy (VCP-MSP), an autosomal dominant, adult-onset disorder causing dysfunction in several tissue types. It can result in complex neurodegenerative conditions including inclusion body myopathy, frontotemporal dementia, amyotrophic lateral sclerosis, or combinations of these. There is also an association with other neurodegenerative phenotypes such as Alzheimer-type dementia and Parkinsonism. Non-neurological presentations include Paget disease of bone and may also include cardiac dysfunction. We provide a detailed discussion of genotype-phenotype correlations, recommendations for genetic diagnosis, and genetic counselling implications of VCP-MSP.

Keywords: VCP; amyotrophic lateral sclerosis; dementia; genetics; genotype-phenotype correlation; multisystem proteinopathy; myopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests to report.

Figures

Figure 1
Figure 1
Pathogenic mutations represented on the 3D model of VCP. (A) Three-dimensional representation of the VCP hexamer. We have color-coded individual domains from a single VCP monomer for ease of reference in subsequent images: Green for the N-terminal domain, blue for the N-D1 linker, yellow for the D1 domain, purple for the D1-D2 linker, light blue for the D2 domain, yellow for the C-terminal domain, with grey lines representing the other 5 structural oligomers. In red, we have represented the locations of pathogenic variants in VCP, showing the positions in the N-terminal domain (B), linker domain (C), D1 domain (D), and D2 domain (E). This figure was generated using open source material available from Swiss model [108] and PyMOL [109] based on the proposed structure of the VCP hexamer [110].

References

    1. Dalal S., Hanson P.I. Membrane traffic: What drives the AAA motor? Cell. 2001;104:5–8. doi: 10.1016/S0092-8674(01)00186-6. - DOI - PubMed
    1. Meyer H., Weihl C.C. The VCP/p97 system at a glance: Connecting cellular function to disease pathogenesis. J. Cell Sci. 2014;127:3877–3883. doi: 10.1242/jcs.093831. - DOI - PMC - PubMed
    1. Rabinovich E., Kerem A., Frohlich K.U., Diamant N., Bar-Nun S. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol. Cell. Biol. 2002;22:626–634. doi: 10.1128/MCB.22.2.626-634.2002. - DOI - PMC - PubMed
    1. Shih Y.T., Hsueh Y.P. VCP and ATL1 regulate endoplasmic reticulum and protein synthesis for dendritic spine formation. Nat. Commun. 2016;7:11020. doi: 10.1038/ncomms11020. - DOI - PMC - PubMed
    1. Rape M., Hoppe T., Gorr I., Kalocay M., Richly H., Jentsch S. Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell. 2001;107:667–677. doi: 10.1016/S0092-8674(01)00595-5. - DOI - PubMed

MeSH terms

Substances